Biocracked
Approach 3, the human outcome, in palette C, natural.

Low-angle side view of an older adult's lower legs and walking shoes mid-stride on a long outdoor paved path in a park, shot with a shallow depth of field. The face is out of frame. Late-morning daylight filters through green trees and casts dappled light across weathered skin, worn grey sneakers and the pavement. Two faint chalk-white distance marks on the path sit in soft focus ahead, suggesting a measured walk test. Plant greens, warm earth-brown soil edges and natural skin tones dominate, with a tiny electric green detail on the shoe's lace tip. The mood is calm, honest and measured, hopeful but cautious, and the image feels like documentary photography with crisp texture and no staged gloss.
Supplements

Urolithin A kanggo Otot: Apa 5 Uji Manungsa Benerané Nampilake?

Dr. Synapse · · 4 min read

Yen sampeyan wis ndelok iklan Mitopure utawa suplemen urolithin A liyane, mesthine sampeyan wis diparingi pawarta yèn suplemen iki "ngrecycle mitokondria" lan mbantu otot supaya tetep enom. Mekanisme iki adhedhasar biologi nyata. Nanging review sistematis lan meta‑analisis anyar sing nglumpukake kabeh uji coba acak ing manungsa sing ditemokake, lan jawaban kanggo "apa tenan bisa nambah kinerja otot?" luwih wajar: mungkin, nanging durung ana sing bisa ngomong kanthi pasti.

Review iki diterbitake ing Frontiers in Nutrition taun 2026 dening Dao lan kancané, lan dadi sing kapisan nglumpukake bukti randomized controlled trial (RCT) babagan urolithin A lan kesehatan otot. Ing ngisor iki apa sing ditemokaké lan apa arti‑e yen sampeyan lagi mutusaké apa tuku.

Apa iku Urolithin A?

Urolithin A (UA) dudu zat sing langsung sampeyan mangan. Iki métabolit sing diprodhuksi déning bakteri usus tartamtu saka ellagitannin lan ellagic acid, polyphenol sing ana ing delima, kenari, sawetara beri, lan panganan sing diwenehi rasa kayu oak. Apa sampeyan bisa ngasilaké UA sing cukup saka panganan mau gumantung marang mikrobioma usus. Sawetara wong bisa ngowahi ellagitannin dadi UA kanthi efisien, nanging akèh wong ngowahaké sethithik utawa malah ora sama sekali. Variabilitas iki dadi alesan komersial kanggo njupuk UA langsung minangka suplemen.

Kapentingan ilmiah fokus marang mitophagy, proses pembersihan seluler sing ngilangi mitokondria rusak. Kualitas mitokondria cenderung mudhun bareng umur, lan otot rangka iku jaringan sing butuh energi gedhé. Ing model kéwan lan sel, UA katon bisa ngrangsang mitophagy lan nambah fungsi otot. Hipotesis yèn iki uga bakal kedadéan ing manungsa cukup masuk akal, nanging isih tetep hipotesis.

Apa sing ditemokake Meta‑Analisis?

Penulis nlusuri PubMed, Embase, Web of Science, lan Scopus nganti Desember 2025 kanggo RCT sing mbandhingaké UA oral karo placebo lan nyathet asil sing ana hubungane karo otot. Saka kéné, mung limang uji coba kanthi total 236 peserta sing ditemokake. Uji‑coba mau béda‑bédané saka segi populasi, dosis, lamanya, lan ukuran asil.

Heterogenitas iki mbatesi apa sing bisa digabung sacara statistik. Mung siji ukuran asil, tes mlaku 6 menit (6MWT), sing bisa dipool, lan mung saka loro uji coba. Asilé:

  • Mean difference gabungan: +17,03 m kanggo UA
  • Interval kapercayan 95 %: -5,33 nganti +39,40 m
  • p‑value: 0,135 (ora signifikan sacara statistik)
  • Analisis sensitivitas (misahake grup placebo tinimbang nggabungake lengan): +18,80 m, 95 % CI -3,24 nganti 40,85, p = 0,095, padha karo asil ndhuwur
  • GRADE certainty: rendah

Interval kapercayan iki penting. Iku nutupi saka penurunan cilik ing jarak mlaku nganti peningkatan sing cukup berarti. Data konsisten karo UA ora nindakake apa-apa, lan uga konsisten karo UA mbantu kanthi moderat. Peningkatan 17 m katon nyenengaké, nanging data ora cukup kanggo mbedakake apa iku bener amarga kebetulan.

Penulis uga nyathet yèn lengan 500 mg lan 1.000 mg saka siji uji coba digabung marang grup placebo sing padha, manut pandhuan Cochrane, supaya ora ngitung peserta placebo kaping pindho. Iki cara statistik sing bener, nanging asil gabungan dadi campuran loro dosis.

Kepiye Kekuatan, Ketahanan, lan Tandha Mitokondria?

Kekuatan otot, ketahanan, kapasitas aerobik, lan biomarker kimia utawa mitokondria direview sacara naratif, ora dipool. Penulis nerangaké temuan iki minangka "tanda eksploratori tinimbang efek sing bisa diulang." Sawetara uji coba nuduhaké owah‑owahan sing positif, nanging populasi, dosis, lan cara ngukuré béda banget kanggo ngukuhaké manfaat sing konsisten. Pemasaran asring nyitat temuan positif individu iki, nanging meta‑analisis kanthi tegas ora nganggep iku bukti.

Napa Buktine Tipis?

Ana sawetara masalah sing nambah kerumitan:

  1. Sampel cilik. 236 wong saka limang uji coba iku data sing winates kanggo suplemen sing dipasarkan sacara masif.
  2. Durasi cekak. Uji coba iki jangka pendek. Penuaan otot kedadéan sajrone pirang‑pirang taun, lan studi iki ora nuduhaké apa UA bisa ngowahi lintasan iku.
  3. Populasi campuran. Peserta béda‑bédané sacara klinis, dadi asil saka siji grup (contone, wong tuwa sing ora aktif) ora mesthi bisa ditrapaké kanggo grup liya (contone, atlit terlatih).
  4. Ukuran asil ora standar. Tanpa endpoint sing seragam, uji coba ora bisa dibandhingaké utawa dipool, mula asil positif sing sumebar ora bisa dijupuk dadi kesimpulan sing kukuh.
  5. Penanda surrogate. Owah‑owahan biomarker mitokondria ora mesthi ateges fungsi otot ing urip saben dina luwih apik.

Kesimpulan penulis prasaja: dibutuhake uji coba sing luwih gedhé, luwih dawa, standar, lan populasi sing luwih cetha sadurunge rekomendasi klinis sing teges bisa digawe. Penting kanggo dicathet yèn penulis ora nduwèni konflik kepentingan komersial, sing wigati ing lapangan iki amarga akèh riset sing dipasangaké karo industri.

Ringkesan Praktis

Dosis ing uji coba. Uji‑coba sing dirembug nggunakake 500 mg lan 1.000 mg saben dina. Yen sampeyan arep nyoba UA, iki dosis sing duwé data uji coba manungsa ndhukung. Ora ana bukti yèn dosis luwih dhuwur luwih apik.

Sapa sing bisa isih mikirake. Wong tuwa sing mobilitasé mudhun, utawa wong sing asupan ellagitannin saka panganan cilik lan kepengin nyoba, iku grup sing paling masuk akal kanggo ndelok manfaat. Sinyal saka 6MWT nuduhaké arah positif. Profil keamanan ing uji coba katon cukup, nanging review iki fokus marang efikasi, mula priksa uji coba individu lan rembugan karo dokter, utamané yen sampeyan ngombe obat utawa nduwèni kondisi medis.

Apa sing bisa diarep‑ake. Aja ngarep‑arep owah‑owahan dramatis ing ukuran otot utawa kekuatan. Skenario paling apik saka data saiki mung kenaikan modest ing ketahanan mlaku sawise sawetara sasi panggunaan konsisten, lan malah kuwi durung dikonfirmasi.

Biaya‑manfaat. Suplemen UA bermerek regane premium, asring luwih dhuwur tinimbang pilihan liya sing wis kabukten. Yen anggaran winates, latihan tahanan, protein sing cukup, turu sing cukup, lan aktivitas aerobik rutin duwé bukti sing luwih kuat kanggo njaga otot lan fungsi mitokondria. UA mung bisa dadi tambahan, ora pengganti. Yen sampeyan penasaran, anggep kaya eksperimen sing ora pasti: gawe baseline (tes mlaku, grip strength, utawa angkat beban sederhana), gunakake UA 3‑4 wulan, lan nilai nganggo ukuran objektif, dudu perasaan pribadi.

Kesimpulan

Urolithin A iku senyawa sing menarik sacara ilmiah kanthi mekanisme sing masuk akal lan cathetan manungsa sing janjeni nanging durung kabukten kanggo otot. Ringkesan paling ketat nganti saiki nuduhaké efek sing positif nanging statistik ora konklusif ing siji ukuran mlaku, karo bukti kapastian sing rendah. Iki dudu "ora kerja", lan uga dudu "wis kabukten". Iki "kita durung ngerti", lan sapa wae sing ngaku yakin wis ngluwihi data sing ana.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field.

A single translucent green tea leaf, its veins backlit, lies on a saturated magenta seamless backdrop beside a small pomegranate rind fragment. Together they form a split, two-part chain: a bright brass chain link made of two interlocking rings, one ring dark amber and one pale green, rests on top. Behind it, one ring has a hairline crack. Shot from a low three-quarter angle with a shallow depth of field, the front link razor sharp and the background softly blurred. Lighting is a crisp, hard key light from the upper left with a soft magenta bounce and a long defined shadow across the surface. The palette is vivid magenta, deep amber, and a small accent of electric green (#00e676) on the leaf edge. The mood is curious and skeptical: promising but unproven, with two parts joined yet not fully tested.
longevity

Urolithin A lan EGCG saka Teh Ijo ing Tikus Model Alzheimer: Apa Sing Ditemokaké

BY NOVA CHEN ·

Loro senyawa alami, urolithin A lan EGCG saka teh ijo, diwènèhi bebarengan marang tikus model Alzheimer. Sawise perawatan, mitokondria lan neuron nuduhaké owah‑owahan signifikan: ekspresi gén fusi lan fission owah, tandha mitofagi mundhak, mitokondria dadi luwih dawa, lan produksi ATP nambah. Kombinasi iki kerep ngluwihi regimen sing mung nganggo siji senyawa. Nanging, perawatan diwènèhi lewat suntikan, dudu suplemen oral, lan isih ana pirang‑pirang pitakonan sing kudu dijawab sadurunge dianggep rekomendasi suplemen.

**Approach:** Conceptual metaphor, in a bold color field palette (D).

A single ripe pomegranate, split open, on a saturated teal backdrop. It is the natural source of urolithin A's precursors. The camera sits at a slightly low three-quarter angle, close enough to show glossy, translucent arils. On the left half, the arils sit dull and tightly packed. On the right, a few arils hold a faint electric green glow, as if lit from within, hinting at a selective response in one place and not another. Behind the fruit, a thin copper wire runs across the frame and is unbroken on one side and fraying on the other, standing for arteries versus brain vessels. Soft, directional studio light from the upper left casts crisp shadows. Mood: curious, restrained, quietly hopeful. No text anywhere.
supplements

Urolithin A Ora Nambah Arteri Sawisé 4 Minggu, Nanging Otak Nanggapi

BY NOVA CHEN ·

Uji double‑blind karo 50 wong diwasa umur 40‑64 taun sing nduwèni obesitas nemokake yèn 1.000 mg urolithin A saben dina nganti patang minggu ora nambah flow‑mediated dilation (FMD), sing dadi endpoint utama. Ukuran mikrovascular periferal uga ora owah. Nanging respon hemodinamik cerebrovascular sing dipicu tugas luwih gedhé sacara signifikan karo urolithin A tinimbang placebo, sanajan prestasi tugas tetep ora berubah. Amarga asil otak iki mung outcome sekunder saka uji cekak lan cilik, iki mung petunjuk, dudu kesimpulan. Ing ngisor iki apa sing dituduhaké data, apa sing ora, lan apa artié kanggo sapa wae sing mikir nggunakake suplemen iki.

Approach: Macro science. Palette: D, bold color field.

Extreme macro photograph of a single human T cell shown as a slightly bumpy, matte-textured sphere with fine microvilli, resting on a surface of smaller, out-of-focus cells. A faint electric green (#00e676) glow shows through a few lipid droplets inside its translucent membrane, hinting at fat-burning. The backdrop is a saturated magenta-violet field that fades from deep plum at the edges to bright magenta behind the cell. The camera sits at a low three-quarter angle with very shallow depth of field, so the foreground cell is crisp and the background melts into soft bokeh. Lighting is a soft, directional key from upper left with a thin rim light that picks out the membrane texture. The look is scanning-electron-microscope realism with subtle color, not cartoon. The mood is curious, quietly skeptical and precise. There is no text and no labels. The composition leaves open space on the right.
longevity

Urolithin A Ngowahi Sel T sing Tuwa Sawisé 4 Minggu: Kejutan Saka Penelitian

BY NOVA CHEN ·

Sebuah uji coba acak sing diterbitake ing *Nature Aging* nemokake yèn panggunaan urolithin A selama patang minggu bisa ngowahi profil imun wong diwasa sing umure setengah abad. Sel T CD8⁺ sing mirip naïve nambah lan kemampuan oksidasi lemaké uga mundhak, sanajan persentase owah‑owahané mung setengah poin. Peneliti mung ngukur biomarker, ora ndeleng apa peserta dadi luwih waras utawa ora kena infèksi, lan studi iki dibiayai déning produsen Mitopure. Kudu dipikirake kanthi kritis.

A wide, softly lit editorial still life on a pale travertine surface. In the center-left, a halved ruby-red pomegranate sits open, its glossy arils spilling in a loose cluster onto the stone. Beside it are a few cracked walnut halves and a small matte ceramic dish holding a pinch of fine cream-colored powder. A single aril catches a bright highlight near the foreground. In the soft-focus background, a sheer linen curtain filters warm morning sunlight, which casts long, gentle shadows across the scene.

On the right side, an elegant older woman's hand, seen only from the wrist down, rests lightly on the surface next to a minimalist glass of water. Her skin shows natural texture and warmth. A slim sprig of dried olive branch and a folded sage-green napkin add quiet, organic accents.

The palette is restrained and modern: deep garnet red, warm walnut brown, oat beige, soft sage, and creamy off-white. The composition leaves generous negative space on the upper right for title text. The depth of field is shallow, with crisp focus on the pomegranate and a creamy bokeh falloff. The lighting is natural, diffused, and slightly golden, in the style of a high-end wellness magazine or a contemporary science and nutrition journal. The mood is calm, clean, and quietly authoritative. The finish is photographic, with fine grain, subtle matte tones, and a premium editorial feel.
supplements

Urolithin A, Postbiotik Saka Delima, Nggawa Tandha Mitophagy ing Wong Tuwa

BY DR. SYNAPSE ·

Urolithin A, senyawa sing diprodhuksi bakteri usus saka polifenol delima lan kenari, wis suwe nuduhaké efek peremajaan otot ing kewan tuwa. Uji klinis fase I pertama ing wong tuwa netepaké yèn senyawa iki aman, bisa mlebu aliran getih, lan ngowahi biomarker mitokondria kanthi dosis 500‑1.000 mg saben dina. Senajan asil nuduhaké perbaikan molekuler, studi iki cilik, wektu cekak, lan mung ngukur biomarker, ora kinerja otot utawa umur panjang.

This page is available in